Aspira Women's Health Files Q3 2024 10-Q
Ticker: AWHL · Form: 10-Q · Filed: 2024-11-19T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Aspira Women's Health filed its Q3 2024 10-Q. Check financials.
AI Summary
Aspira Women's Health Inc. filed a 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key financial data and business operations for this period are detailed within the report.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Aspira Women's Health, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial health and operational details within this report will determine the actual risk.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter and year-to-date period covered by the report.)
- 2024-11-19 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of the reporting period
- 2024-11-19 (date) — Filing date
- VERMILLION, INC. (company) — Former company name
- CIPHERGEN BIOSYSTEMS INC (company) — Former company name
- ABIOTIC SYSTEMS (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 19, 2024.
What were the previous names of Aspira Women's Health Inc.?
Aspira Women's Health Inc. was formerly known as VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC, and ABIOTIC SYSTEMS.
What is the Standard Industrial Classification (SIC) code for Aspira Women's Health Inc.?
The SIC code for Aspira Women's Health Inc. is 2835, which corresponds to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.
What is the fiscal year end for Aspira Women's Health Inc.?
The fiscal year end for Aspira Women's Health Inc. is December 31.
From the Filing
0001493152-24-046836.txt : 20241119 0001493152-24-046836.hdr.sgml : 20241119 20241119163554 ACCESSION NUMBER: 0001493152-24-046836 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241119 DATE AS OF CHANGE: 20241119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 241476746 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 10-Q 1 form10-q.htm false --12-31 Q3 0000926617 P1Y 0000926617 2024-01-01 2024-09-30 0000926617 2024-11-18 0000926617 2024-09-30 0000926617 2023-12-31 0000926617 2024-07-01 2024-09-30 0000926617 2023-07-01 2023-09-30 0000926617 2023-01-01 2023-09-30 0000926617 us-gaap:ProductMember 2024-07-01 2024-09-30 0000926617 us-gaap:ProductMember 2023-07-01 2023-09-30 0000926617 us-gaap:ProductMember 2024-01-01 2024-09-30 0000926617 us-gaap:ProductMember 2023-01-01 2023-09-30 0000926617 AWH:GeneticsMember 2024-07-01 2024-09-30 0000926617 AWH:GeneticsMember 2023-07-01 2023-09-30 0000926617 AWH:GeneticsMember 2024-01-01 2024-09-30 0000926617 AWH:GeneticsMember 2023-01-01 2023-09-30 0000926617 us-gaap:CommonStockMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2024-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000926617 us-gaap:RetainedEarningsMember 2024-03-31 0000926617 2024-03-31 0000926617 us-gaap:CommonStockMember 2024-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000926617 us-gaap:RetainedEarningsMember 2024-06-30 0000926617 2024-06-30 0000926617 us-gaap:CommonStockMember 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-12-31 0000926617 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000926617 us-gaap:RetainedEarningsMember 2023-03-31 0000926617 2023-03-31 0000926617 us-gaap:CommonStockMember 2023-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000926617 us-gaap:RetainedEarningsMember 2023-06-30 0000926617 2023-06-30 0000926617 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000926617 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000926617 2024-01-01 2024-03-31 0000926617 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000926617 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000926617 2024-04-01 2024-06-30 0000926617 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000926617 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000926617 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000926617 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000926617 2023-01-01 2023-03-31 0000926617 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000926617 us-gaap:RetainedEarningsMember